Search Results

Agonist-Trafficking and Hallucinogens

Authors: Gonzalez-Maeso, Javier; Sealfon, Stuart C.

Source: Current Medicinal Chemistry, Volume 16, Number 8, March 2009 , pp. 1017-1027(11)

Publisher: Bentham Science Publishers

. . . and ergot-derived dopamine agonists . . .

Source: Reactions, Volume 1, Number 1209, 2008-07-05 , pp. 2-2(1)

Publisher: Adis International

Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice

Authors: LALOUX, CHARLOTTE; DERAMBURE, PHILIPPE; HOUDAYER, ELISE; JACQUESSON, JEAN-MARIE; BORDET, RÉGIS; DESTÉE, ALAIN; MONACA, CHRISTELLE

Source: Journal of Sleep Research, Volume 17, Number 1, March 2008 , pp. 101-110(10)

Publisher: Blackwell Publishing

Manage levodopa-induced motor complications in patients with Parkinson's disease with careful selection of other antiparkinsonian agents

Author: Adis International Limited,

Source: Drugs & Therapy Perspectives, Volume 24, Number 1, January 2008 , pp. 17-21(5)

Publisher: Adis International

Transdermal drug delivery in Parkinson's disease

Author: Pfeiffer, Ronald F

Source: Aging Health, Volume 3, Number 4, August 2007 , pp. 471-482(12)

Publisher: Future Medicine

Medical Management of Levodopa-Associated Motor Complications in Patients with Parkinson's Disease

Authors: Jankovic, Joseph; Stacy, Mark

Source: CNS Drugs, Volume 21, Number 8, 2007 , pp. 677-692(16)

Publisher: Adis International

Dopamine Stimulation via Infusion in the Lateral Ventricle

Authors: BIAGIONI, FRANCESCA; BUSCETI, CARLA L.; MOLINARO, GEMMA; BATTAGLIA, GIUSEPPE; GIORGI, FILIPPO S.; RUGGIERI, STEFANO; FORNAI, FRANCESCO

Source: Annals of the New York Academy of Sciences, Volume 1074, Number 1, August 2006 , pp. 337-343(7)

Publisher: Blackwell Publishing

Dopamine Stimulation via Infusion in the Lateral Ventricle

Authors: BIAGIONI, FRANCESCA; BUSCETI, CARLA L.; MOLINARO, GEMMA; BATTAGLIA, GIUSEPPE; GIORGI, FILIPPO S.; RUGGIERI, STEFANO; FORNAI, FRANCESCO

Source: Annals of the New York Academy of Sciences, Volume 1074, Number 1, August 2006 , pp. 337-343(7)

Publisher: Blackwell Publishing

Striking differences of action of lisuride stereoisomers at histamine H₁ receptors

Authors: Pertz, Heinz; Görnemann, Tilo; Schurad, Björn; Seifert, Roland; Straßer, Andrea

Source: Naunyn-Schmiedeberg's Archives of Pharmacology, Volume 374, Number 3, December 2006 , pp. 215-222(8)

Publisher: Springer

Transdermal Treatment Options for Neurological Disorders: Impact on the Elderly

Authors: Priano, Lorenzo; Maria Rosa Gasco,; Mauro, Alessandro

Source: Drugs & Aging, Volume 23, Number 5, 2006 , pp. 357-375(19)

Publisher: Adis International

Albert Hofmann's Pioneering Work on Ergot Alkaloids and Its Impact on the Search of Novel Drugs at Sandoz, a Predecessor Company of Novartis: Dedicated to Dr. Albert Hofmann on the occasion of his 100th birthday

Authors: Giger, Rudolf K.A.; Engel, Günter

Source: CHIMIA International Journal for Chemistry, Volume 60, Numbers 1-2, February 2006 , pp. 83-87(5)

Publisher: Swiss Chemical Society

Pharmacokinetic Optimisation in the Treatment of Parkinson's Disease: An Update

Author: Nyholm, Dag

Source: Clinical Pharmacokinetics, Volume 45, Number 2, 2006 , pp. 109-136(28)

Publisher: Adis International

Tritiation of dopaminergic ligands (-)-lisuride and (+/-)-nomifensine

Authors: Filer, C. N.; Hainley, Ch.; Nugent, R. P.

Source: Journal of Radioanalytical and Nuclear Chemistry, Volume 267, Number 2, January 2006 , pp. 345-348(4)

Publisher: Springer

Advances in the delivery of treatments for Parkinson’s disease

Authors: Johnston, Tom H; Fox, Susan H; Brotchie, Jonathan M

Source: Expert Opinion on Drug Delivery, Volume 2, Number 6, 1 November 2005 , pp. 1059-1073(15)

Publisher: Informa Healthcare

Treatment of Pituitary Tumors: Dopamine Agonists

Authors: Iván, Gabriella; Szigeti-Csúcs, Nikoletta; Oláh, Márk; Nagy, György M.; Góth, Miklós I.

Source: Endocrine, Volume 28, Number 1, October 2005 , pp. 101-110(10)

Publisher: Humana Press

Evidence for the management of mastalgia

Authors: Gumm, R.; Cunnick, G.H.; Mokbel, K.

Source: Current Medical Research and Opinion, Volume 20, Number 5, 1 May 2004 , pp. 681-684(4)

Publisher: Informa Healthcare

The dopamine receptor agonist lisuride attenuates iron-mediated dopaminergic neurodegeneration

Authors: Double K.L.; Halliday G.M.; Henderson J.; Griffiths F.M.; Heinemann T.; Riederer P.; Gerlach M.

Source: Experimental Neurology, Volume 184, Number 1, November 2003 , pp. 530-535(6)

Publisher: Elsevier

Prevention and treatment of motor fluctuations

Author: Stocchi F.

Source: Parkinsonism and Related Disorders, Volume 9, Supplement 2, August 2003 , pp. 73-81(9)

Publisher: Elsevier

Characterization of the 5-HT₆ receptor coupled to Ca²⁺ signaling using an enabling chimeric G-protein

Authors: Zhang J.Y.; Nawoschik S.; Kowal D.; Smith D.; Spangler T.; Ochalski R.; Schechter L.; Dunlop J.

Source: European Journal of Pharmacology, Volume 472, Number 1, 4 July 2003 , pp. 33-38(6)

Publisher: Elsevier

Managing the critical problems of advanced Parkinson’s disease

Author: Stocchi, Fabrizio

Source: Expert Review of Neurotherapeutics, Volume 2, Number 6, November 2002 , pp. 835-847(13)

Publisher: Expert Reviews